LGR5 and endometrium adenocarcinoma: The more advanced stages of endometrial adenocarcinomas (stages III and IV) have a greater SOX9+LGR5+ signal (Wilcoxon test, stages I + II against stages III + IV, P value 7.54 × 10−6) (Fig. 3b and Supplementary Table 3).